Cargando…
Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies
The consistency of in vitro drug sensitivity data is of key importance for cancer pharmacogenomics. Previous attempts to correlate drug sensitivities from the large pharmacogenomics databases, such as the Cancer Cell Line Encyclopedia (CCLE) and the Genomics of Drug Sensitivity in Cancer (GDSC), hav...
Autores principales: | Pozdeyev, Nikita, Yoo, Minjae, Mackie, Ryan, Schweppe, Rebecca E., Tan, Aik Choon, Haugen, Bryan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239501/ https://www.ncbi.nlm.nih.gov/pubmed/27322211 http://dx.doi.org/10.18632/oncotarget.10010 |
Ejemplares similares
-
BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer
por: Rose, Madison M., et al.
Publicado: (2023) -
Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials
por: Federer, Callie, et al.
Publicado: (2016) -
Uncovering drug repurposing candidates for head and neck cancers: insights from systematic pharmacogenomics data analysis
por: Chai, Annie Wai Yeeng, et al.
Publicado: (2021) -
Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis
por: Kessler, Brittelle E., et al.
Publicado: (2018) -
K-Map: connecting kinases with therapeutics for drug repurposing and development
por: Kim, Jihye, et al.
Publicado: (2013)